Cite
HARVARD Citation
Garfall, A. et al. (2022). Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy. Journal of clinical oncology. 40 (1), pp. 106-107. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Garfall, A. et al. (2022). Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy. Journal of clinical oncology. 40 (1), pp. 106-107. [Online].